DR. SUSAN K. BONAR, M.D.

Plain English
This study looked at the views of manufacturers and technicians who create and support communication devices for people with speech difficulties. Researchers gathered a group of these professionals in Canada and found that they face challenges in making devices user-friendly while also needing more financial support to help users effectively. They believe that better funding and more access to these devices for users could improve communication outcomes significantly for those in need. Who this helps: This helps patients with speech difficulties and the professionals supporting them.

Plain English
This study looked at how well olanzapine, a medication usually used for treating mental health issues, can help relieve nausea and vomiting in patients receiving palliative care—not those undergoing chemotherapy. Out of 78 patients, those who took olanzapine required fewer doses of other nausea medications (down from an average of 1.6 to 0.6 doses), and many showed improved appetite. Most importantly, using olanzapine also helped reduce the cost of nausea medication and was safely prescribed to 69% of patients discharged from the hospital. Who this helps: This benefits patients in palliative care who struggle with nausea and vomiting.

Plain English
This study looked at the role of a protein called Smad4 in bone-building cells, specifically how it interacts with Wnt signaling to control cell growth and development. Researchers found that when Smad4 is removed from these cells, the rate of cell division increases significantly, while the process of maturation slows down. Specifically, removing Smad4 led to more rapid cell division on the bone surface, but reduced the ability of these cells to produce a mineralized bone matrix. This matters because understanding how to control cell growth and differentiation can help improve bone healing and treatment for bone-related diseases. Who this helps: This helps patients with bone disorders and fractures by providing insights that could lead to better treatments.

Plain English
This study focused on developing new drugs that specifically target a protein called p38 kinase, which is involved in inflammation. Researchers created a series of compounds and found that two of them, labeled as compounds 2 and 3, were especially effective at reducing inflammation in both short-term and long-term experiments. These findings are important because they could lead to new treatments for inflammatory conditions, improving patient care. Who this helps: Patients with inflammatory diseases.

Plain English
Researchers developed a new drug called PH-797804, which specifically targets a protein called p38 MAP kinase involved in inflammation. They tested its effectiveness and found that it is a strong and precise inhibitor, showing promise for treating inflammatory diseases. This discovery is important because it could lead to better treatments for conditions like arthritis and other inflammatory disorders. Who this helps: Patients suffering from inflammatory diseases.

Plain English
This research looked at a new group of compounds designed to block a specific enzyme called IKK-2, which is involved in inflammation. Out of 21 different compounds tested, six were found to significantly reduce the production of an inflammatory substance called IL-8 in cells from patients with rheumatoid arthritis. This matters because lowering IL-8 can help reduce inflammation and improve symptoms for people with this condition. Who this helps: This benefits patients with rheumatoid arthritis.

Plain English
This study looked at a new drug called SC-514, which targets a specific enzyme (IKK-2) involved in the inflammation process, particularly in diseases like arthritis. Researchers found that SC-514 effectively blocks the gene activity driven by a protein called NF-kappa B in cells from patients with rheumatoid arthritis when stimulated by interleukin-1 beta. Specifically, it reduced this gene activity in a measurable way, showing that lower doses of the drug led to decreased inflammatory responses. Who this helps: This research benefits patients with inflammatory diseases like rheumatoid arthritis by providing a potential new treatment option.

Plain English
This study explored a new method for inserting screws into interlocking nails for bone fractures, focusing on a specific technique called the "third point in space." The researchers found that this method worked well in over 30 cases and is simple, reliable, and cost-effective, eliminating the need for expensive tools. This matters because it can make surgeries easier and safer for patients with bone fractures. Who this helps: Patients with femoral and tibial fractures.

Plain English
Researchers studied the treatment of severe ankle fractures (tibial plafond fractures) in 48 patients using a special external device called an articulated external fixator. They found that all fractures healed, and infections were rare, with only two cases of minor infections that were successfully treated. This approach helped minimize complications and provided good outcomes, with an average ankle score of 67 points after two years. Who this helps: This benefits patients with severe ankle fractures seeking effective treatment options.

Plain English
This study focused on a Korean woman who repeatedly experienced cholangitis, a liver infection, due to a condition called Oriental cholangiohepatitis, which has become more common in the U.S. as more people from East Asia immigrate. The symptoms are similar to those caused by gallstones, but the causes and treatments are very different. Recognizing this condition is important, especially in patients with a history of certain parasitic infections or who have lived in areas where the disease is common. Who this helps: This helps doctors diagnose and treat patients with liver infections accurately.